An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly

NCT01995734 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: Pasireotide long acting release formulation

Sponsor

Novartis Pharmaceuticals